Marburg I mutant of factor VII-activating protease (FSAP) as risk factor for arterial thrombosis
Details for Australian Patent Application No. 2003201328 (hide)
International Classifications
Event Publications
3 April 2003 Complete Application Filed
Priority application(s): 102 12 246.6 19.03.02 DE; 102 38 429.0 16.08.02 DE
9 October 2003 Application Open to Public Inspection
Published as AU-B-2003201328
17 March 2005 Change of Name(s) of Applicant(s), Section 104
Aventis Behring GmbH The name of the applicant has been changed to ZLB Behring GmbH
31 May 2007 Application Accepted
Published as AU-B-2003201328
23 August 2007 Change of Name(s) of Applicant(s), Section 104
ZLB Behring GmbH The name of the applicant has been changed to CSL Behring GmbH
27 September 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003201329-A System and Method for Optimising Halftoning Printer Performance
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser